Published in Sci Rep on November 10, 2015
A systematic review and meta-analysis-does chronic obstructive pulmonary disease predispose to bronchopleural fistula formation in patients undergoing lung cancer surgery? J Thorac Dis (2016) 0.81
Evidence from a large-scale meta-analysis indicates eczema reduces the incidence of glioma. Oncotarget (2016) 0.79
Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study. Oncotarget (2016) 0.75
Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs. Allergy Asthma Clin Immunol (2016) 0.75
Statin Therapy Is Associated with Reduced Risk of Peptic Ulcer Disease in the Taiwanese Population. Front Pharmacol (2017) 0.75
Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD? J Clin Med (2016) 0.75
The Effects of Statins on Pulmonary Artery Pressure in Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. J Res Pharm Pract (2017) 0.75
Statins Dose-Dependently Exert Significant Chemopreventive Effects Against Various Cancers in Chronic Obstructive Pulmonary Disease Patients: A Population-Based Cohort Study. J Cancer (2016) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health (1998) 17.71
Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol (2005) 5.30
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med (2002) 4.11
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
Statin use and risk of COPD exacerbation requiring hospitalization. Am J Med (2013) 2.29
Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Int J Clin Pract (2013) 2.09
Pulmonary hypertension in COPD. Eur Respir J (2008) 2.03
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol (2006) 1.91
Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res (2009) 1.85
Statins in COPD: a systematic review. Chest (2009) 1.82
Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Clin Sci (Lond) (2009) 1.69
Statin use is associated with reduced mortality in COPD. Eur Respir J (2006) 1.66
Statin use in COPD patients is associated with a reduction in mortality: a national cohort study. Prim Care Respir J (2012) 1.58
COPD and cancer mortality: the influence of statins. Thorax (2009) 1.53
Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development. Circ Res (2003) 1.38
Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol (2007) 1.20
Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract (2008) 1.20
Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Thromb Haemost (2009) 1.13
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999. COPD (2005) 1.12
Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.12
Statins, systemic inflammation and risk of death in COPD: the Rotterdam study. Pulm Pharmacol Ther (2012) 1.04
Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan. Tohoku J Exp Med (2007) 1.04
Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD. COPD (2011) 1.04
Associations between statins and COPD: a systematic review. BMC Pulm Med (2009) 0.99
Statin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study in Taiwan. Clin Ther (2011) 0.92
Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol (2008) 0.91
Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies. Respir Res (2014) 0.90
Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgrad Med J (2009) 0.90
Statins and outcome after hospitalization for COPD exacerbation: a prospective study. Pulm Pharmacol Ther (2011) 0.89
Simvastatin attenuates experimental small airway remodelling in rats. Respirology (2009) 0.86
Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study. Clin Ther (2012) 0.85
Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway. Int Immunopharmacol (2010) 0.85
Non-atheroprotective effects of statins: a systematic review. Am J Cardiovasc Drugs (2009) 0.85
Treating systemic effects of COPD. Trends Pharmacol Sci (2007) 0.79
Smoking-promoted oxidative DNA damage response is highly correlated to lung carcinogenesis. Oncotarget (2016) 0.76
Proteomic analysis of sputum reveals novel biomarkers for various presentations of asthma. J Transl Med (2017) 0.75